SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-07-069315
Filing Date
2007-12-27
Accepted
2007-12-27 15:48:39
Documents
1
Period of Report
2007-12-27

Document Format Files

Seq Description Document Type Size
1 v098246_ex.html 3  
1 v098246_ex.xml 3 3370
  Complete submission text file 0001144204-07-069315.txt   5322
Mailing Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TRANSDEL PHARMACEUTICALS, INC. 4225 EXECUTIVE SQUARE, SUITE 460 LA JOLLA CA 92037
Business Address (858) 457-5300
Brar Balbir (Reporting) CIK: 0001421384 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52998 | Film No.: 071329091